Aspirin Use May Change Cost-effectiveness of COX-2 Inhibitors—Reply

[1]  J. Dalen.  Selective COX-2 Inhibitors, NSAIDs, aspirin, and myocardial infarction. , 2002, Archives of internal medicine.

[2]  H. Guess,et al.  Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis. , 2002, Archives of internal medicine.

[3]  E. Rahme,et al.  Association between naproxen use and protection against acute myocardial infarction. , 2002, Archives of internal medicine.

[4]  Daniel H Solomon,et al.  Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. , 2002, Archives of internal medicine.

[5]  C Michael Stein,et al.  Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study , 2002, The Lancet.

[6]  M. Boers.  NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection , 2001, The Lancet.

[7]  R Day,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[8]  R. Makuch,et al.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.

[9]  J. Senior,et al.  Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs , 1995, Annals of Internal Medicine.

[10]  J. Cairns,et al.  Antithrombotic agents in coronary artery disease. , 1989, Chest.